P101 has announced that it has invested €5 million in TeiaCare, leading a funding round totalling €7 million. In addition to the existing shareholders, two new investors specialising in the healthcare sector – the Spanish family offices Namarel and Inderhabs – are also participating in the round. Inderhabs, in particular, combines its investments in the sector with a direct presence in the residential care sector.
TeiaCare develops care monitoring solutions for residential social and healthcare facilities, including nursing homes, residential care homes, intermediate care units, hospices and units dedicated to residents with Alzheimer’s or other forms of dementia. Through Ancelia, the proprietary platform developed by the company, TeiaCare supports nurses, care staff, doctors, managers and coordinators with tools that enhance care awareness, promote personalised care and improve decision-making.
Using a system of optical sensors and artificial intelligence algorithms, Ancelia monitors the environments within residential care homes and transforms the data collected into useful insights to help prevent risky situations, support the development of care plans and optimise the daily work of staff.
Founded by Guido Magrin and Luca Iozzia in 2018, TeiaCare now works with over 150 clients and more than 200 care homes, whose 75,000 residents account for a quarter of the total in Italy, establishing itself as a leading provider in Italy and one of the few specialist operators active in Europe.
The company operates in a particularly sensitive sector that is under considerable pressure. In Italy today, there are around 300,000 people living in residential care homes, with just as many on the waiting list. Added to this are around four million people who require home care. The sector is also burdened by a growing staff shortage. It is estimated that there is currently a shortfall of around 50,000 nurses and that, for every 100 inpatients, only one nurse and two social and healthcare workers are available on night shifts in these facilities.
“In a context where the fragility of the residential social and healthcare sector is becoming increasingly apparent, technology has rapidly gone from being an opportunity to being a necessity,” says Guido Magrin, CEO and co-founder of TeiaCare, in a statement (pictured here with Iozzia) – “Today we have a unique opportunity to help define a new category of care solutions: practical tools to support care professionals, improve the quality of life for vulnerable people and tackle one of the great challenges of our time – an ageing population – in a systematic way.”
TeiaCare will use the new capital to accelerate the scaling of its business model into new geographical and functional areas. The aim is to evolve its offering through the development of advanced data, spatial and care intelligence solutions, including by extending application models from the residential sector to the healthcare and home care sectors. Thanks to the operational support of P101, the company will also embark on international expansion, with an immediate focus on France and Spain, promoting a model of continuity of care through synergy between hospitals, care homes and home care services.
P101’s investment in TeiaCare comes at a time of strong growth in the healthtech sector, which accounts for around 20% of the investments made through Programme 103. In particular, when its various segments are taken together, the health and life sciences sector also stands out in terms of capital raised in 2025, with around €600 million invested by venture capital funds, as highlighted in the recent ‘State of Italian VC’ report compiled by P101 itself.
“Technology in healthcare is becoming increasingly central: it enhances the potential for care, reduces inefficiencies and improves the quality of services. We are firmly committed to healthtech, in which we have already invested 20% of the capital allocated to Programme 103,” says Stefano Guidotti, partner at P101 “And in a sector as sensitive and complex as the one in which TeiaCare operates, I am convinced that technology can offer invaluable added value. TeiaCare has already come a long way, establishing itself as a leader in Italy. Thanks to a flexible and scalable solution, it will be able to grow rapidly on an international level, starting in Southern Europe, where it will be able to introduce a solution that is unrivalled. We are therefore delighted to be able to support them in this new phase of development.”
With this transaction, P101 SGR completes its fourteenth investment made through Programme 103, Azimut Eltif Venture Capital P103 and Programme 103R Digital. Programme 103 is also supported by the European Union through the InvestEU Fund, and Programme 103R Digital is supported by CDP Venture Capital, including through the Digital Transition – PNRR fund, which utilises resources allocated by the EU via the NextGeneration EU initiative, with the aim of promoting the digital transition of supply chains and small and medium-sized enterprises.
ALL RIGHTS RESERVED ©